Pharmaceutical Sales Strategies for Diabetes Care

Success in the diabetes market is driven by educating physicians on evolving standards of care and patients on lifestyle and treatment adherence.

The management of diabetes and metabolic syndrome is impeded by patient and clinician barriers. As the prevalence of diabetes has reached epidemic proportions and is growing by 3% each year, new classes of diabetes agents are being developed for better control of glucose levels. Standards of care for diabetes are evolving and, in addition to control of blood glucose levels, new considerations include cardiovascular safety, obesity, nephropathy, retinopathy, and medication side effects. Within this environment of shifting priorities, clinicians may be reluctant to optimize therapy in a timely fashion. Moreover, patient adherence to pharmacologic treatment is low. Prevention of diabetes through lifestyle management of metabolic syndrome through diet and exercise combined with the careful use of pharmaceutic agents has become another priority, but is also impeded by low patient adherence.

PDI’s clinical and sales teams are ready to help your customers provide effective diabetes care.

Successful pharmaceutical sales strategies in the diabetes and metabolic disease market center on physician and patient education. PDI’s medical science liaisons (MSLs) offer physicians expert education on emerging treatments, changing guidelines, and timely treatment optimization, while PDI’s clinical health educators (CHEs) provide the patient education required to increase treatment adherence and ensure the effectiveness of lifestyle interventions. Inside and field-based medical sales representatives can also help you support your education-driven strategy.

Physicians and patients require education on evolving standards of care with shifting priorities:

  • Clinician education on timely optimization of therapy and on patient-centered counseling to promote lifestyle management of metabolic syndrome
  • Patient and provider education on the risks and benefits of emerging classes of antidiabetic agents, risk/benefit considerations, and side effect management
  • Critical patient education for successful lifestyle interventions and raising treatment adherence

Learn how we can help healthcare professionals provide effective, timely diabetes care

Contact Us Now